France Bans Oral Nicotine Products in Forms of Pouches, Pastes, Tablets, and Liquids Starting March 2026

Sep.08
France Bans Oral Nicotine Products in Forms of Pouches, Pastes, Tablets, and Liquids Starting March 2026
France's Decree No. 2025-898 bans all oral nicotine products nationwide six months after publication. Medicines and medical devices are exempt. This includes nicotine pouches, gum, lozenges, and other forms, regardless of origin. The decree is based on the Public Health Code and applies to mainland France and Wallis and Futuna Islands.

Key Points:

 

·Ban Scope: The production, manufacture, transport, import, export, possession, offer/sale, purchase, and use of these products are prohibited within France.

·Formats include: nicotine pouches (including porous pouches), pastes, beads, liquids, chewing gum, lozenges, films/strips, etc. (regardless of whether the nicotine is natural or synthetic).

·Exemptions:
1. Chewing tobacco;
2. Legally approved pharmaceuticals, medical devices, and their medicinal raw materials;
3. Food (naturally containing trace amounts of nicotine or meeting EU pesticide residue limits).

·Research Exceptions: Case-by-case exemptions for research purposes may be issued by the Minister of Health, subject to separate conditions and procedures.

·Effective Date: Le Monde and Radio France Internationale reported that the ban will officially take effect in March 2026.

 


 

2Firsts, September 8, 2025 - According to the French government's official website on September 5, the French government published Decree No. 2025-898 in the Official Gazette, which will take effect six months from its publication. This ban applies nationwide to the production, sale, possession, purchase, and use of "nicotine-containing products for oral use," with the exception of medicines and medical devices.

 

The decree specifies that the ban covers all stages of the process: production, manufacturing, transportation, import/export, possession, provision/transfer, purchase, and actual use.

 

Formats subject to the ban include:

 

Nicotine pouches (including porous pouches), pastes, beads, liquids, chewing gum, lozenges, films/strips, and more (regardless of whether the nicotine is natural or synthetic).

 

Exemptions include:

 

·Chewing tobacco;

·Legally approved medicines, medical devices, and their medicinal raw materials;

·Food (naturally containing nicotine or meeting EU pesticide residue limits).

 

The decree provides for scientific research exceptions, which can be granted for specific research projects upon the signature of the Minister of Health and in compliance with specified conditions.

 

The background document states that nicotine is classified as a "toxic substance" under the French Public Health Code, allowing for a ban on "any related operation" by decree of the Council of State. The decree has also been submitted to the European Union for technical regulatory information (notification number 2025/0110/FR) as required.

 

The decree indicates that, in addition to mainland France, the relevant provisions also apply to the Wallis and Futuna Islands.

 

Le Monde and Radio France Internationale reported that the ban will officially take effect in March 2026.

 

Chill Brands acquires UK exclusive distribution rights for ELF nicotine pouches, also distributing ELFBAR and Lost Mary e-cigarettes
Chill Brands acquires UK exclusive distribution rights for ELF nicotine pouches, also distributing ELFBAR and Lost Mary e-cigarettes
Chill Brands Group has partnered with ELF Nicotine Pouches, appointing as its master distributor in the UK. Products will be distributed through the Chill Connect channel. All items are manufactured by Shenzhen iMiracle Technology, which also produces ELFBAR and Lost Mary e-cigarettes. The agreement covers distribution of ELF nicotine pouches, ELFBAR, and Lost Mary products across UK convenience stores.
Sep.11 by 2FIRSTS.ai
A Representative From International Business Department Business Manager, CTAIC, Attended the 2Firsts Global NGP Rethink Forum and Delivered a Keynote Speech
A Representative From International Business Department Business Manager, CTAIC, Attended the 2Firsts Global NGP Rethink Forum and Delivered a Keynote Speech
Krystal Fan, Business Manager at CTAIC, spoke at the 2Firsts Global NGP Rethink Forum, sharing insights on the development, culture, features, and strategy of the Crown Cigar brand.
Aug.01 by 2FIRSTS.ai
Hanover County, Virginia Police Crack Down on Vape Shops: 11 Establishments Caught Selling Cigarettes Illegally, 5 Arrested for Marijuana Distribution
Hanover County, Virginia Police Crack Down on Vape Shops: 11 Establishments Caught Selling Cigarettes Illegally, 5 Arrested for Marijuana Distribution
n the United States, Hanover County, Virginia intensified enforcement against illegal activity at vape shops over July and August—charging 16 people, seizing more than 20 pounds of marijuana valued at over $100,000, and finding that 11 of 13 shops sold products to underage decoys. The county also approved new siting rules for future vape shops, while the 22 existing stores are exempt.
Sep.09
Philippines Doubles Minimum Vape Prices; 2ml Pods Now $6
Philippines Doubles Minimum Vape Prices; 2ml Pods Now $6
The Philippines’ Bureau of Internal Revenue on July 18 announced new rules raising minimum prices for tobacco and vape products. The price of a 2ml nicotine pod will nearly double to PHP 353.18 (about $6). The regulation takes effect 15 days after publication.
Jul.21 by 2FIRSTS.ai
2Firsts Interview | Adding Evidence: How Two Recent Blu Studies Strengthen the Case for NGPs As THR Tools
2Firsts Interview | Adding Evidence: How Two Recent Blu Studies Strengthen the Case for NGPs As THR Tools
2Firsts interviewed Elizabeth Clarke, scientific lead at Imperial Brands, on the latest blu behavioral studies. Results showed that smokers with no intention to quit reduced cigarette use by nearly 29% in one week, and about one-third to 40% had significantly reduced or quit at six months. Clarke highlighted the role of flavor diversity and behavioral science, urging science-based harm reduction policies to demonstrate blu’s public health potential.
Jul.17
Japan Tobacco’s Greece Subsidiary Posts $900 Million Revenue in 2024, Plans to Boost Ploom Market Expansion
Japan Tobacco’s Greece Subsidiary Posts $900 Million Revenue in 2024, Plans to Boost Ploom Market Expansion
Japan Tobacco International’s (JTI) Greece operations are projected to generate over €800 million (approximately $900 million) in revenue in 2024, with a net profit of €958,000 (about $1.11 million), marking a growth in market share despite challenging conditions. JTI’s innovation is driving market expansion in Greece, with its Ploom products successfully entering the market.
Jul.18 by 2FIRSTS.ai